Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

NCT05304585 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

205

Enrollment

NETWORK

Sponsor class

Conditions

Embryonal Rhabdomyosarcoma
Fusion-Negative Alveolar Rhabdomyosarcoma
Spindle Cell/Sclerosing Rhabdomyosarcoma

Interventions

PROCEDURE: Biopsy Procedure
PROCEDURE: Bone Scan
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
BIOLOGICAL: Dactinomycin
PROCEDURE: Magnetic Resonance Elastography
PROCEDURE: Positron Emission Tomography
RADIATION: Radiation Therapy
DRUG: Vincristine

Sponsor

Children's Oncology Group

Collaborators

National Cancer Institute (NCI)